Global Human Immunoglobulin Market Insights and Forecast to 2026
- BMR3903829
- 119 Pages
- June 2020
- Healthcare
Prior to COVID-19, the market for Human Immunoglobulin was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Human Immunoglobulin is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Human Immunoglobulin market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Immunoglobulin market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Human Immunoglobulin industry.
Global Human Immunoglobulin Scope and Segment
Human Immunoglobulin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Immunoglobulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Takeda
CSL
Grifols
Octapharma
Biotest
China National Pharmaceutical Group Corporation
CTBB
Hualan Bio
RASS
Shanxi Kangbao Biological Product
Shuanglin Bio Pharma
Sichuan Yuanda Shuyang Pharmaceutical
Human Immunoglobulin Breakdown Data by Type
Intramuscular Injection
Intravenous Injection
Human Immunoglobulin Breakdown Data by Application
Disease Prevention
Treatment
Diagnosis
Other
Regional and Country-level Analysis
The Human Immunoglobulin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Immunoglobulin market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Human Immunoglobulin Market Share Analysis
1.1 Human Immunoglobulin Product Introduction
1.2 Market Segments
1.3 Key Human Immunoglobulin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Immunoglobulin Market Size Growth Rate by Type
1.4.2 Intramuscular Injection
1.4.3 Intravenous Injection
1.5 Market by Application
1.5.1 Global Human Immunoglobulin Market Size Growth Rate by Application
1.5.2 Disease Prevention
1.5.3 Treatment
1.5.4 Diagnosis
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Immunoglobulin Market Size, Estimates and Forecasts
2.1.1 Global Human Immunoglobulin Revenue 2015-2026
2.1.2 Global Human Immunoglobulin Sales 2015-2026
2.2 Global Human Immunoglobulin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Immunoglobulin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Immunoglobulin Competitor Landscape by Players
3.1 Human Immunoglobulin Sales by Manufacturers
3.1.1 Human Immunoglobulin Sales by Manufacturers (2015-2020)
3.1.2 Human Immunoglobulin Sales Market Share by Manufacturers (2015-2020)
3.2 Human Immunoglobulin Revenue by Manufacturers
3.2.1 Human Immunoglobulin Revenue by Manufacturers (2015-2020)
3.2.2 Human Immunoglobulin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Immunoglobulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Immunoglobulin Revenue in 2019
3.2.5 Global Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Immunoglobulin Price by Manufacturers
3.4 Human Immunoglobulin Manufacturing Base Distribution, Product Types
3.4.1 Human Immunoglobulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Immunoglobulin Product Type
3.4.3 Date of International Manufacturers Enter into Human Immunoglobulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Immunoglobulin Market Size by Type (2015-2020)
4.1.1 Global Human Immunoglobulin Sales by Type (2015-2020)
4.1.2 Global Human Immunoglobulin Revenue by Type (2015-2020)
4.1.3 Human Immunoglobulin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Immunoglobulin Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Immunoglobulin Sales Forecast by Type (2021-2026)
4.2.2 Global Human Immunoglobulin Revenue Forecast by Type (2021-2026)
4.2.3 Human Immunoglobulin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Immunoglobulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Immunoglobulin Market Size by Application (2015-2020)
5.1.1 Global Human Immunoglobulin Sales by Application (2015-2020)
5.1.2 Global Human Immunoglobulin Revenue by Application (2015-2020)
5.1.3 Human Immunoglobulin Price by Application (2015-2020)
5.2 Human Immunoglobulin Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Immunoglobulin Sales Forecast by Application (2021-2026)
5.2.2 Global Human Immunoglobulin Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Immunoglobulin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Immunoglobulin by Country
6.1.1 North America Human Immunoglobulin Sales by Country
6.1.2 North America Human Immunoglobulin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Immunoglobulin Market Facts & Figures by Type
6.3 North America Human Immunoglobulin Market Facts & Figures by Application
7 Europe
7.1 Europe Human Immunoglobulin by Country
7.1.1 Europe Human Immunoglobulin Sales by Country
7.1.2 Europe Human Immunoglobulin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Immunoglobulin Market Facts & Figures by Type
7.3 Europe Human Immunoglobulin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Immunoglobulin by Region
8.1.1 Asia Pacific Human Immunoglobulin Sales by Region
8.1.2 Asia Pacific Human Immunoglobulin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Immunoglobulin Market Facts & Figures by Type
8.3 Asia Pacific Human Immunoglobulin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Immunoglobulin by Country
9.1.1 Latin America Human Immunoglobulin Sales by Country
9.1.2 Latin America Human Immunoglobulin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Immunoglobulin Market Facts & Figures by Type
9.3 Central & South America Human Immunoglobulin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Immunoglobulin by Country
10.1.1 Middle East and Africa Human Immunoglobulin Sales by Country
10.1.2 Middle East and Africa Human Immunoglobulin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Immunoglobulin Market Facts & Figures by Type
10.3 Middle East and Africa Human Immunoglobulin Market Facts & Figures by Application
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Description and Business Overview
11.1.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Takeda Human Immunoglobulin Products Offered
11.1.5 Takeda Related Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Description and Business Overview
11.2.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CSL Human Immunoglobulin Products Offered
11.2.5 CSL Related Developments
11.3 Grifols
11.3.1 Grifols Corporation Information
11.3.2 Grifols Description and Business Overview
11.3.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Grifols Human Immunoglobulin Products Offered
11.3.5 Grifols Related Developments
11.4 Octapharma
11.4.1 Octapharma Corporation Information
11.4.2 Octapharma Description and Business Overview
11.4.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Octapharma Human Immunoglobulin Products Offered
11.4.5 Octapharma Related Developments
11.5 Biotest
11.5.1 Biotest Corporation Information
11.5.2 Biotest Description and Business Overview
11.5.3 Biotest Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biotest Human Immunoglobulin Products Offered
11.5.5 Biotest Related Developments
11.6 China National Pharmaceutical Group Corporation
11.6.1 China National Pharmaceutical Group Corporation Corporation Information
11.6.2 China National Pharmaceutical Group Corporation Description and Business Overview
11.6.3 China National Pharmaceutical Group Corporation Sales, Revenue and Gross Margin (2015-2020)
11.6.4 China National Pharmaceutical Group Corporation Human Immunoglobulin Products Offered
11.6.5 China National Pharmaceutical Group Corporation Related Developments
11.7 CTBB
11.7.1 CTBB Corporation Information
11.7.2 CTBB Description and Business Overview
11.7.3 CTBB Sales, Revenue and Gross Margin (2015-2020)
11.7.4 CTBB Human Immunoglobulin Products Offered
11.7.5 CTBB Related Developments
11.8 Hualan Bio
11.8.1 Hualan Bio Corporation Information
11.8.2 Hualan Bio Description and Business Overview
11.8.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Hualan Bio Human Immunoglobulin Products Offered
11.8.5 Hualan Bio Related Developments
11.9 RASS
11.9.1 RASS Corporation Information
11.9.2 RASS Description and Business Overview
11.9.3 RASS Sales, Revenue and Gross Margin (2015-2020)
11.9.4 RASS Human Immunoglobulin Products Offered
11.9.5 RASS Related Developments
11.10 Shanxi Kangbao Biological Product
11.10.1 Shanxi Kangbao Biological Product Corporation Information
11.10.2 Shanxi Kangbao Biological Product Description and Business Overview
11.10.3 Shanxi Kangbao Biological Product Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Shanxi Kangbao Biological Product Human Immunoglobulin Products Offered
11.10.5 Shanxi Kangbao Biological Product Related Developments
11.1 Takeda
11.1.1 Takeda Corporation Information
11.1.2 Takeda Description and Business Overview
11.1.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Takeda Human Immunoglobulin Products Offered
11.1.5 Takeda Related Developments
11.12 Sichuan Yuanda Shuyang Pharmaceutical
11.12.1 Sichuan Yuanda Shuyang Pharmaceutical Corporation Information
11.12.2 Sichuan Yuanda Shuyang Pharmaceutical Description and Business Overview
11.12.3 Sichuan Yuanda Shuyang Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Sichuan Yuanda Shuyang Pharmaceutical Products Offered
11.12.5 Sichuan Yuanda Shuyang Pharmaceutical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Immunoglobulin Market Estimates and Projections by Region
12.1.1 Global Human Immunoglobulin Sales Forecast by Regions 2021-2026
12.1.2 Global Human Immunoglobulin Revenue Forecast by Regions 2021-2026
12.2 North America Human Immunoglobulin Market Size Forecast (2021-2026)
12.2.1 North America: Human Immunoglobulin Sales Forecast (2021-2026)
12.2.2 North America: Human Immunoglobulin Revenue Forecast (2021-2026)
12.2.3 North America: Human Immunoglobulin Market Size Forecast by Country (2021-2026)
12.3 Europe Human Immunoglobulin Market Size Forecast (2021-2026)
12.3.1 Europe: Human Immunoglobulin Sales Forecast (2021-2026)
12.3.2 Europe: Human Immunoglobulin Revenue Forecast (2021-2026)
12.3.3 Europe: Human Immunoglobulin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Immunoglobulin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Immunoglobulin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Immunoglobulin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Immunoglobulin Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Immunoglobulin Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Immunoglobulin Sales Forecast (2021-2026)
12.5.2 Latin America: Human Immunoglobulin Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Immunoglobulin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Immunoglobulin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Immunoglobulin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Immunoglobulin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Immunoglobulin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Human Immunoglobulin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Immunoglobulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Human Immunoglobulin Market Segments
Table 2. Ranking of Global Top Human Immunoglobulin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Immunoglobulin Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Intramuscular Injection
Table 5. Major Manufacturers of Intravenous Injection
Table 6. Global Human Immunoglobulin Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Human Immunoglobulin Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Human Immunoglobulin Sales by Regions 2015-2020 (K MT)
Table 9. Global Human Immunoglobulin Sales Market Share by Regions (2015-2020)
Table 10. Global Human Immunoglobulin Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Human Immunoglobulin Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Human Immunoglobulin Sales Share by Manufacturers (2015-2020)
Table 13. Global Human Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Human Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunoglobulin as of 2019)
Table 15. Human Immunoglobulin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Human Immunoglobulin Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Human Immunoglobulin Price (2015-2020) (USD/MT)
Table 18. Human Immunoglobulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Human Immunoglobulin Product Type
Table 20. Date of International Manufacturers Enter into Human Immunoglobulin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Human Immunoglobulin Sales by Type (2015-2020) (K MT)
Table 23. Global Human Immunoglobulin Sales Share by Type (2015-2020)
Table 24. Global Human Immunoglobulin Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Human Immunoglobulin Revenue Share by Type (2015-2020)
Table 26. Human Immunoglobulin Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Human Immunoglobulin Sales by Application (2015-2020) (K MT)
Table 28. Global Human Immunoglobulin Sales Share by Application (2015-2020)
Table 29. North America Human Immunoglobulin Sales by Country (2015-2020) (K MT)
Table 30. North America Human Immunoglobulin Sales Market Share by Country (2015-2020)
Table 31. North America Human Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Human Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 33. North America Human Immunoglobulin Sales by Type (2015-2020) (K MT)
Table 34. North America Human Immunoglobulin Sales Market Share by Type (2015-2020)
Table 35. North America Human Immunoglobulin Sales by Application (2015-2020) (K MT)
Table 36. North America Human Immunoglobulin Sales Market Share by Application (2015-2020)
Table 37. Europe Human Immunoglobulin Sales by Country (2015-2020) (K MT)
Table 38. Europe Human Immunoglobulin Sales Market Share by Country (2015-2020)
Table 39. Europe Human Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Human Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 41. Europe Human Immunoglobulin Sales by Type (2015-2020) (K MT)
Table 42. Europe Human Immunoglobulin Sales Market Share by Type (2015-2020)
Table 43. Europe Human Immunoglobulin Sales by Application (2015-2020) (K MT)
Table 44. Europe Human Immunoglobulin Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Human Immunoglobulin Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Human Immunoglobulin Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Human Immunoglobulin Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Human Immunoglobulin Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Human Immunoglobulin Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Human Immunoglobulin Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Human Immunoglobulin Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Human Immunoglobulin Sales Market Share by Application (2015-2020)
Table 53. Latin America Human Immunoglobulin Sales by Country (2015-2020) (K MT)
Table 54. Latin America Human Immunoglobulin Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Human Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Human Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 57. Latin America Human Immunoglobulin Sales by Type (2015-2020) (K MT)
Table 58. Latin America Human Immunoglobulin Sales Market Share by Type (2015-2020)
Table 59. Latin America Human Immunoglobulin Sales by Application (2015-2020) (K MT)
Table 60. Latin America Human Immunoglobulin Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Human Immunoglobulin Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Human Immunoglobulin Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Human Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Human Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Human Immunoglobulin Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Human Immunoglobulin Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Human Immunoglobulin Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Human Immunoglobulin Sales Market Share by Application (2015-2020)
Table 69. Takeda Corporation Information
Table 70. Takeda Description and Major Businesses
Table 71. Takeda Human Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Takeda Product
Table 73. Takeda Recent Development
Table 74. CSL Corporation Information
Table 75. CSL Description and Major Businesses
Table 76. CSL Human Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. CSL Product
Table 78. CSL Recent Development
Table 79. Grifols Corporation Information
Table 80. Grifols Description and Major Businesses
Table 81. Grifols Human Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Grifols Product
Table 83. Grifols Recent Development
Table 84. Octapharma Corporation Information
Table 85. Octapharma Description and Major Businesses
Table 86. Octapharma Human Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Octapharma Product
Table 88. Octapharma Recent Development
Table 89. Biotest Corporation Information
Table 90. Biotest Description and Major Businesses
Table 91. Biotest Human Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Biotest Product
Table 93. Biotest Recent Development
Table 94. China National Pharmaceutical Group Corporation Corporation Information
Table 95. China National Pharmaceutical Group Corporation Description and Major Businesses
Table 96. China National Pharmaceutical Group Corporation Human Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. China National Pharmaceutical Group Corporation Product
Table 98. China National Pharmaceutical Group Corporation Recent Development
Table 99. CTBB Corporation Information
Table 100. CTBB Description and Major Businesses
Table 101. CTBB Human Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. CTBB Product
Table 103. CTBB Recent Development
Table 104. Hualan Bio Corporation Information
Table 105. Hualan Bio Description and Major Businesses
Table 106. Hualan Bio Human Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Hualan Bio Product
Table 108. Hualan Bio Recent Development
Table 109. RASS Corporation Information
Table 110. RASS Description and Major Businesses
Table 111. RASS Human Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. RASS Product
Table 113. RASS Recent Development
Table 114. Shanxi Kangbao Biological Product Corporation Information
Table 115. Shanxi Kangbao Biological Product Description and Major Businesses
Table 116. Shanxi Kangbao Biological Product Human Immunoglobulin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Shanxi Kangbao Biological Product Product
Table 118. Shanxi Kangbao Biological Product Recent Development
Table 119. Shuanglin Bio Pharma Corporation Information
Table 120. Shuanglin Bio Pharma Description and Major Businesses
Table 121. Shuanglin Bio Pharma Human Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Shuanglin Bio Pharma Product
Table 123. Shuanglin Bio Pharma Recent Development
Table 124. Sichuan Yuanda Shuyang Pharmaceutical Corporation Information
Table 125. Sichuan Yuanda Shuyang Pharmaceutical Description and Major Businesses
Table 126. Sichuan Yuanda Shuyang Pharmaceutical Human Immunoglobulin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Sichuan Yuanda Shuyang Pharmaceutical Product
Table 128. Sichuan Yuanda Shuyang Pharmaceutical Recent Development
Table 129. Global Human Immunoglobulin Sales Forecast by Regions (2021-2026) (K MT)
Table 130. Global Human Immunoglobulin Sales Market Share Forecast by Regions (2021-2026)
Table 131. Global Human Immunoglobulin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 132. Global Human Immunoglobulin Revenue Market Share Forecast by Regions (2021-2026)
Table 133. North America: Human Immunoglobulin Sales Forecast by Country (2021-2026) (K MT)
Table 134. North America: Human Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Europe: Human Immunoglobulin Sales Forecast by Country (2021-2026) (K MT)
Table 136. Europe: Human Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Asia Pacific: Human Immunoglobulin Sales Forecast by Region (2021-2026) (K MT)
Table 138. Asia Pacific: Human Immunoglobulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Latin America: Human Immunoglobulin Sales Forecast by Country (2021-2026) (K MT)
Table 140. Latin America: Human Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Middle East and Africa: Human Immunoglobulin Sales Forecast by Country (2021-2026) (K MT)
Table 142. Middle East and Africa: Human Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Market Risks
Table 146. Main Points Interviewed from Key Human Immunoglobulin Players
Table 147. Human Immunoglobulin Customers List
Table 148. Human Immunoglobulin Distributors List
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Immunoglobulin Product Picture
Figure 2. Global Human Immunoglobulin Sales Market Share by Type in 2020 & 2026
Figure 3. Intramuscular Injection Product Picture
Figure 4. Intravenous Injection Product Picture
Figure 5. Global Human Immunoglobulin Sales Market Share by Application in 2020 & 2026
Figure 6. Disease Prevention
Figure 7. Treatment
Figure 8. Diagnosis
Figure 9. Other
Figure 10. Human Immunoglobulin Report Years Considered
Figure 11. Global Human Immunoglobulin Market Size 2015-2026 (US$ Million)
Figure 12. Global Human Immunoglobulin Sales 2015-2026 (K MT)
Figure 13. Global Human Immunoglobulin Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Human Immunoglobulin Sales Market Share by Region (2015-2020)
Figure 15. Global Human Immunoglobulin Sales Market Share by Region in 2019
Figure 16. Global Human Immunoglobulin Revenue Market Share by Region (2015-2020)
Figure 17. Global Human Immunoglobulin Revenue Market Share by Region in 2019
Figure 18. Global Human Immunoglobulin Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Human Immunoglobulin Revenue in 2019
Figure 20. Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Human Immunoglobulin Sales Market Share by Type (2015-2020)
Figure 22. Global Human Immunoglobulin Sales Market Share by Type in 2019
Figure 23. Global Human Immunoglobulin Revenue Market Share by Type (2015-2020)
Figure 24. Global Human Immunoglobulin Revenue Market Share by Type in 2019
Figure 25. Global Human Immunoglobulin Market Share by Price Range (2015-2020)
Figure 26. Global Human Immunoglobulin Sales Market Share by Application (2015-2020)
Figure 27. Global Human Immunoglobulin Sales Market Share by Application in 2019
Figure 28. Global Human Immunoglobulin Revenue Market Share by Application (2015-2020)
Figure 29. Global Human Immunoglobulin Revenue Market Share by Application in 2019
Figure 30. North America Human Immunoglobulin Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Human Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Human Immunoglobulin Sales Market Share by Country in 2019
Figure 33. North America Human Immunoglobulin Revenue Market Share by Country in 2019
Figure 34. U.S. Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Human Immunoglobulin Market Share by Type in 2019
Figure 39. North America Human Immunoglobulin Market Share by Application in 2019
Figure 40. Europe Human Immunoglobulin Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Human Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Human Immunoglobulin Sales Market Share by Country in 2019
Figure 43. Europe Human Immunoglobulin Revenue Market Share by Country in 2019
Figure 44. Germany Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Human Immunoglobulin Market Share by Type in 2019
Figure 55. Europe Human Immunoglobulin Market Share by Application in 2019
Figure 56. Asia Pacific Human Immunoglobulin Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Human Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Human Immunoglobulin Sales Market Share by Region in 2019
Figure 59. Asia Pacific Human Immunoglobulin Revenue Market Share by Region in 2019
Figure 60. China Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Human Immunoglobulin Market Share by Type in 2019
Figure 83. Asia Pacific Human Immunoglobulin Market Share by Application in 2019
Figure 84. Latin America Human Immunoglobulin Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Human Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Human Immunoglobulin Sales Market Share by Country in 2019
Figure 87. Latin America Human Immunoglobulin Revenue Market Share by Country in 2019
Figure 88. Mexico Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Human Immunoglobulin Market Share by Type in 2019
Figure 95. Latin America Human Immunoglobulin Market Share by Application in 2019
Figure 96. Middle East and Africa Human Immunoglobulin Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Human Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Human Immunoglobulin Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Human Immunoglobulin Revenue Market Share by Country in 2019
Figure 100. Turkey Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Human Immunoglobulin Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Human Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Human Immunoglobulin Market Share by Type in 2019
Figure 107. Middle East and Africa Human Immunoglobulin Market Share by Application in 2019
Figure 108. North America Human Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Human Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Human Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Human Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Human Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Human Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Human Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Human Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Human Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Human Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
